Biocompatibility of white cell filters as evaluated by complement activation.
The biocompatibility of nine different white cell filters was examined by analysis of complement activation in plasma specimens obtained from blood components before and after filtration. Filters for both red cell (RBC) concentrates and platelet concentrates (PCs) were tested. It was found in all of the filters tested that the postfiltration levels of complement activation products were not higher than the prefiltration levels in RBC concentrates and PCs. One exception was the filtration of multiple PCs with Imugard IG-500, in which case a rise in C3 activation products was seen. Moreover, there was a significant rise in C3 activation products, but not the terminal complement complex, when plasma was filtered through Imugard E, which contrasted with results with the other filters. High initial and storage time-dependent levels, especially of C3 activation products, were observed in the PCs, probably due to their processing at room temperature. It can be concluded that the majority of the filters tested do not activate complement.
Hetland
G
G
Blood Bank, Ullevaal Hospital, Oslo, Norway.
Mollnes
T E
TE
Larsen
J
J
Garred
P
P
D001792:Blood Platelets / Q000166:cytology; D002469:Cell Separation / Q000379:methods; D003167:Complement Activation; D003176:Complement C3 / Q000276:immunology; D004912:Erythrocytes / Q000166:cytology; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000166:cytology*; D008422:Materials Testing
D003176:Complement C3